Skip to main content
TRANS GENIC GROUP INC. logo

TRANS GENIC GROUP INC. — Investor Relations & Filings

Ticker · 2342 ISIN · JP3635720000 T Professional, scientific and technical activities
Open in API
Filings indexed 67 across all filing types
Latest filing 2026-05-14 Regulatory Filings
Country JP Japan
Listing T 2342

About TRANS GENIC GROUP INC.

https://transgenic-group.co.jp/

TRANS GENIC GROUP INC. is a biotechnology company that operates through two main business segments: Drug Discovery Support and Investment & Consulting. The Drug Discovery Support division provides comprehensive services across the entire drug development pipeline, from basic research to non-clinical and clinical trials. Core services include the contract production of genetically modified animals, particularly mice, using genome editing technologies like CRISPR/Cas9. The company also specializes in contract antibody production, glycosylation analysis, and the supply of model mice. The Investment & Consulting segment focuses on M&A, business succession, and providing advisory and support services for business revitalization.

Recent filings

Filing Released Lang Actions
臨時報告書
Regulatory Filings Classification · 85% confidence The document is a Japanese "臨時報告書" (Timely Disclosure Report) filed under the Financial Instruments and Exchange Law, detailing material events affecting the company’s financial condition (e.g., debt forgiveness, impairment losses, GLP non-compliance compensation). It is not a periodic interim or annual report, nor is it an announcement of publication; rather it is an ad hoc regulatory filing similar to a Form 8-K/6-K. No specific category for ad hoc event reports exists, so it defaults to Regulatory Filings (RNS).
2026-05-14 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references '金融商品取引法第24条の５の２第１項' (Article 24-5-2, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification regarding the accuracy of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a report (like a semi-annual report), should be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements. H1 28
2025-11-13 Japanese
半期報告書－第28期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed with the Fukuoka Local Finance Bureau under the Financial Instruments and Exchange Act. It contains comprehensive financial statements, including the balance sheet, income statement, and cash flow analysis for the interim period (April 1, 2025, to September 30, 2025). As it provides substantive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2026
2025-11-13 Japanese
訂正確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act, specifically related to a correction of a Securities Report (有価証券報告書). Since it is a regulatory filing confirming the accuracy of a previously filed report and does not fit into the specific categories like 10-K or IR (as it is a confirmation of a correction), it falls under the general regulatory filings category. FY 2025
2025-08-01 Japanese
訂正有価証券報告書－第27期(2024/04/01－2025/03/31)
Annual Report Classification · 100% confidence The document is identified as a '訂正有価証券報告書' (Amended Securities Report) for the fiscal year ending March 31, 2025. In the Japanese regulatory context, '有価証券報告書' (Yuuka Shouken Houkokusho) is the equivalent of the US 10-K annual report. The document contains detailed financial data, XBRL tags, and corporate information, confirming it is the report itself rather than an announcement. Therefore, it is classified as a 10-K. FY 2025
2025-08-01 Japanese
訂正臨時報告書
Regulatory Filings Classification · 100% confidence The document is titled "訂正臨時報告書" (Corrected Extraordinary Report) and explicitly states it is being filed based on Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act and related Cabinet Office Ordinance (企業内容等の開示に関する内閣府令第19条第２項第９号の４). The content details the proposed change of the statutory auditor (会計監査人), including the name of the retiring auditor (有限責任監査法人トーマツ) and the proposed new auditor (有限責任パートナーズ綜合監査法人), scheduled for the upcoming General Shareholders' Meeting. This type of filing, concerning significant corporate governance or statutory changes reported outside of regular periodic filings (like 10-K or IR), falls under the category of an Extraordinary Report or a specific regulatory disclosure. Given the options, this relates to a significant corporate event requiring immediate disclosure, which is best captured by the general 'Regulatory Filings' (RNS) or potentially a specific governance/audit report if one existed. Since the core subject is the change of the statutory auditor, which is a mandatory disclosure under Japanese regulations, and it is explicitly labeled as an 'Extraordinary Report' (臨時報告書), it fits best under the general regulatory filing category (RNS) as there is no specific code for 'Auditor Change Report'. The document length is short, but it is the report itself, not an announcement of a report, thus RPA is not appropriate.
2025-07-02 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.